Labcorp (LH) and OPKO Health (OPK) announced earlier on Tuesday that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO ...

Labcorp will acquire BioReference Health's oncology diagnostics operations as the lab company works to expand in high-growth testing areas.

Burlington, North Carolina Wednesday, March 12, 2025, 14:00 Hrs [IST] ...

The sale comes after the Miami company agreed to pay $704,349 to settle allegations that it billed the federal government for ...

Labcorp has entered into an agreement to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO ...

Labcorp Holdings has signed a deal to buy certain assets of OPKO Health's BioReference Health unit for up to $225 million. Labcorp on Tuesday said it will pay $192.5 million at closing for ...

Labcorp (LH) and OPKO Health (OPK) announced that they have entered into an agreement for Labcorp to acquire select assets of BioReference ...

HC Wainwright dropped their Q2 2025 earnings per share (EPS) estimates for OPKO Health in a note issued to investors on Monday, March 3rd. HC Wainwright analyst Y. Chen now forecasts that the ...

HC Wainwright reissued their buy rating on shares of OPKO Health (NASDAQ:OPK – Free Report) in a report published on Monday morning,Benzinga reports. They currently have a $3.00 price objective on the ...

OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and 12 months ended December 31, 2024. Highlights from the fourth ...